trial · primary record
ITI-1284 10 mg
Generalized Anxiety Disorder
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 570 |
| Primary completion | 2028-07-20 |
| Primary endpoint | Hamilton Anxiety Rating Scale (HAM-A) |
| Registry ID | NCT06701903 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:08.540Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06701903
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- ITI-1284 10 mg · compound